Jan-08-21 Downgrade
Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade
BTIG Research
Buy → Neutral
Aug-20-20 Initiated
Oppenheimer
Outperform
$75
May-29-20 Initiated
BTIG Research
Buy
$20
Nov-05-19 Upgrade
Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade
Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-14-21 12:07PM
Jan-13-21 06:59AM
Jan-09-21 08:29AM
02:55AM
Jan-08-21 11:58AM
Jan-06-21 09:25AM
08:00AM
Dec-31-20 01:05PM
Dec-29-20 12:52PM
08:00AM
06:37AM
Dec-21-20 01:20PM Investor's Business Daily +12.08%
Dec-17-20 04:02PM
06:47AM
Dec-15-20 10:07AM
Dec-14-20 08:37AM
08:30AM
Dec-11-20 11:15AM
10:54AM Investor's Business Daily
07:03AM
Dec-10-20 05:45PM
10:40AM
09:56AM
08:44AM
Dec-09-20 06:50AM
Dec-07-20 09:06AM
Dec-05-20 04:00PM
Dec-02-20 09:57PM
Dec-01-20 11:10AM Investor's Business Daily
Nov-30-20 10:42AM Investor's Business Daily +10.56%
Nov-27-20 06:14AM
Nov-26-20 07:14AM
Nov-25-20 09:17AM
12:27AM
Nov-24-20 08:00AM
Nov-23-20 08:00AM
Nov-18-20 08:30AM
Nov-17-20 08:54AM
07:38AM
Nov-10-20 04:05PM
12:33PM
04:31AM
Nov-09-20 04:05PM
02:45PM
Nov-04-20 07:57AM
Oct-26-20 08:00AM
Sep-30-20 08:00AM
Sep-22-20 07:59AM
Sep-21-20 06:41PM
Sep-20-20 10:18AM
Sep-15-20 08:00AM
Sep-09-20 08:00AM
Sep-04-20 10:29AM
08:00AM
Sep-03-20 12:20PM
12:08PM
07:55AM
06:00AM
Sep-02-20 09:25PM
04:05PM
Sep-01-20 09:42AM
Aug-27-20 04:27PM
12:23PM
Aug-21-20 01:28PM
Aug-20-20 09:51AM
Aug-17-20 07:00AM
Aug-05-20 07:26AM
06:01AM
Aug-04-20 04:05PM
Jul-14-20 08:00AM
Jun-25-20 12:28PM
Jun-17-20 10:32AM
09:49AM Investor's Business Daily
03:05AM
Jun-16-20 04:05PM
May-22-20 02:32AM Thomson Reuters StreetEvents
May-18-20 06:00AM
May-05-20 11:00AM
May-04-20 04:05PM
Apr-16-20 08:17AM
Apr-09-20 08:01AM
08:00AM
Mar-27-20 03:22AM Thomson Reuters StreetEvents -9.75%
Mar-17-20 08:00AM
Mar-10-20 04:23PM
04:05PM
02:30PM
08:00AM
Mar-02-20 09:44AM
Feb-24-20 08:28AM
Feb-20-20 08:00AM
Feb-07-20 07:54AM
Feb-06-20 03:34PM
11:23AM
11:17AM
Jan-24-20 06:51AM
Jan-20-20 11:30AM
Jan-03-20 08:22AM
Jan-02-20 10:19AM
Dec-20-19 06:38PM
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home Covid-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KIM PAUL CFO and Treasurer Dec 10 Sale 51.94 16,958 880,734 174,563 Dec 11 06:26 PM KIM PAUL CFO and Treasurer Dec 09 Sale 51.60 10,662 550,189 191,521 Dec 11 06:26 PM KIM PAUL CFO and Treasurer Dec 02 Sale 46.58 29,949 1,395,133 202,183 Dec 04 04:06 PM Xie Jian Chief Operating Officer Dec 02 Sale 46.00 1,000 46,000 431,689 Dec 02 06:03 PM Xie Jian Chief Operating Officer Dec 01 Sale 45.16 1,000 45,160 432,689 Dec 02 06:03 PM Xie Jian Chief Operating Officer Nov 30 Sale 43.22 3,396 146,762 433,689 Dec 02 06:03 PM Xie Jian Chief Operating Officer Nov 23 Sale 44.08 6,000 264,480 437,085 Nov 24 05:24 PM Xie Jian Chief Operating Officer Nov 20 Sale 42.50 1,000 42,500 443,085 Nov 24 05:24 PM Xie Jian Chief Operating Officer Nov 18 Sale 44.83 3,000 134,500 444,085 Nov 19 08:15 PM BOLGER JOHN C Director Nov 17 Option Exercise 0.38 2,631 1,000 4,644 Nov 18 07:48 PM Xie Jian Chief Operating Officer Nov 17 Sale 45.34 3,706 168,012 447,085 Nov 19 08:15 PM Gao Hanlin Chief Scientific Officer Nov 17 Sale 45.45 301 13,680 813,391 Nov 18 07:50 PM BOLGER JOHN C Director Nov 17 Sale 44.24 4,269 188,877 375 Nov 18 07:48 PM KIM PAUL CFO and Treasurer Nov 17 Sale 45.45 3,767 171,206 232,132 Nov 18 07:52 PM KIM PAUL CFO and Treasurer Nov 16 Sale 46.17 100,000 4,616,980 235,899 Nov 18 07:52 PM KIM PAUL CFO and Treasurer Sep 02 Sale 28.32 425 12,035 335,899 Sep 03 08:45 PM Xie Jian Chief Operating Officer Aug 28 Sale 30.82 441 13,591 601,295 Sep 23 07:35 PM KIM PAUL CFO and Treasurer Aug 19 Sale 44.16 25,407 1,122,039 335,774 Aug 19 09:14 PM BOLGER JOHN C Director Aug 17 Option Exercise 12.31 2,631 32,393 5,927 Aug 19 09:09 PM KIM PAUL CFO and Treasurer Aug 17 Sale 41.65 111,236 4,633,097 361,181 Aug 19 09:14 PM Gao Hanlin Chief Scientific Officer Aug 17 Sale 41.11 1,308 53,772 1,281,351 Aug 19 09:11 PM BOLGER JOHN C Director Aug 17 Sale 40.87 3,914 159,967 2,013 Aug 19 09:09 PM KIM PAUL CFO and Treasurer Aug 11 Sale 42.06 1,396 58,712 472,417 Aug 12 04:28 PM Xie Jian Chief Operating Officer Aug 03 Sale 27.86 1,976 55,055 601,736 Aug 05 08:57 PM KIM PAUL CFO and Treasurer Jun 02 Sale 18.06 425 7,674 433,813 Jun 03 05:14 PM BOLGER JOHN C Director May 22 Option Exercise 2.11 5,131 10,812 11,973 May 27 07:48 PM BOLGER JOHN C Director May 22 Sale 15.36 8,677 133,288 3,296 May 27 07:48 PM KIM PAUL CFO and Treasurer May 12 Sale 16.31 1,421 23,176 434,238 May 13 07:13 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite